BioCentury | Jan 14, 2008
Clinical News

Tissera preclinical data

...near-normal blood sugar levels. Animals were completely independent of exogenous insulin at 5 months post-transplant. Tissera Inc....
BioCentury | Mar 27, 2006
Clinical News

Tissera preclinical data

...significant proliferation of the transplanted cells. In addition, no signs of host rejection were detected. Tissera Inc....
BioCentury | Apr 26, 2004
Company News

Tissera scientific advisory board update

Tissera Inc. (TSSR), Tel Aviv, Israel Business: Transplant Appointed: Giuseppe Remuzzi, director of the Mario Negri Institute for Pharmacological Research; Sir Roy Caln, professor of surgery at the National University of Singapore WIR Staff...
BioCentury | Apr 19, 2004
Company News

Tissera scientific advisory board update

Tissera Inc. (TSSR), Tel Aviv, Israel Business: Transplant Appointed: Abraham Shaked, professor of surgery at the University of Pennsylvania WIR Staff Transplant...
BioCentury | Feb 23, 2004
Company News

Tissera management update

Tissera Inc. (TSSR), Tel Aviv, Israel Business: Transplant Hired: Vicki Rabenou as CEO, formerly president and CEO of the Rad BioMed Incubator WIR Staff Transplant...
BioCentury | Feb 19, 2004
Company News

Tissera hires Rabenou as CEO

...Vicki Rabenou as CEO. Previously, Rabenou was president and CEO of the Rad BioMed Incubator. Tissera...
Items per page:
1 - 6 of 6
BioCentury | Jan 14, 2008
Clinical News

Tissera preclinical data

...near-normal blood sugar levels. Animals were completely independent of exogenous insulin at 5 months post-transplant. Tissera Inc....
BioCentury | Mar 27, 2006
Clinical News

Tissera preclinical data

...significant proliferation of the transplanted cells. In addition, no signs of host rejection were detected. Tissera Inc....
BioCentury | Apr 26, 2004
Company News

Tissera scientific advisory board update

Tissera Inc. (TSSR), Tel Aviv, Israel Business: Transplant Appointed: Giuseppe Remuzzi, director of the Mario Negri Institute for Pharmacological Research; Sir Roy Caln, professor of surgery at the National University of Singapore WIR Staff...
BioCentury | Apr 19, 2004
Company News

Tissera scientific advisory board update

Tissera Inc. (TSSR), Tel Aviv, Israel Business: Transplant Appointed: Abraham Shaked, professor of surgery at the University of Pennsylvania WIR Staff Transplant...
BioCentury | Feb 23, 2004
Company News

Tissera management update

Tissera Inc. (TSSR), Tel Aviv, Israel Business: Transplant Hired: Vicki Rabenou as CEO, formerly president and CEO of the Rad BioMed Incubator WIR Staff Transplant...
BioCentury | Feb 19, 2004
Company News

Tissera hires Rabenou as CEO

...Vicki Rabenou as CEO. Previously, Rabenou was president and CEO of the Rad BioMed Incubator. Tissera...
Items per page:
1 - 6 of 6